Clontech Laboratories Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Clontech Laboratories's estimated annual revenue is currently $22.3M per year.(i)
  • Clontech Laboratories's estimated revenue per employee is $155,000

Employee Data

  • Clontech Laboratories has 144 Employees.(i)
  • Clontech Laboratories grew their employee count by 0% last year.

Clontech Laboratories's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Clontech Laboratories?

Takara Bio Europe is a member of the Takara Bio Group, a leading supplier of tools for life scientists worldwide. We serve customers in a wide range of scientific settings, including academic institutions, government research facilities, clinical research, and pharmaceuticals in Europe, Middle East and Africa. We are a dynamic team of professionals, all dedicated to providing best-in-class solutions to research scientists in advanced biology. Quality, efficiency and the care of our customers, suppliers and staff are paramount to the way we work. With offices in Paris, France and Göteborg, Sweden, Takara Bio Europe is an outstanding place to work offering the unique opportunity to take an independent position within a European organization. We are always looking for skilled and motivated professionals. At Takara Bio, we strive to deliver innovative technologies that help push every experiment to its fullest potential. Through our brand names TAKARA®, CLONTECH® and CELLARTIS™ we develop innovative technologies in the fields of Cell Biology, Molecular Biology, Proteomics and Stem Cell Research. Key products include SMART cDNA synthesis kits for a variety of samples and applications, including NGS, high-performance qPCR and PCR reagents, Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins. Recently, Takara Bio acquired Rubicon Genomics and WaferGen Bio-systems. As part of the Takara Bio family, they expand our NGS portfolio as well as add R&D, manufacturing, and support for automation systems for NGS and qPCR applications. Takara Bio's portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit takarabio.com. Our best-in-class products are backed by expert technical assistance, because good science needs great support.

keywords:N/A

N/A

Total Funding

144

Number of Employees

$22.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Clontech Laboratories News

2022-04-19 - Machine learning-aided engineering of hydrolases for PET ...

Stellar Competent Cells (Clontech Laboratories) were used as the cloning host and transformed with the ligated plasmids using the heat-shock...

2022-04-17 - Protein Fractionation Market Size, Outlook And Forecast ...

Clontech, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Qiagen, Affymetrix, ... Bio-Rad Laboratories, Agilent Technologies, Bruker Corporation.

2022-04-13 - Enhanced serodiagnosis of melioidosis by indirect ELISA ...

However, owing to the limited availability of laboratory ... min at 4 °C and 2 mL of equilibrated TALON™ resins (Clontech Laboratories Inc.,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.4M144-3%N/A
#2
$28M14416%N/A
#3
$15M1447%N/A
#4
$47.2M14431%$132M
#5
$15M1441%N/A